PMID: 2502505Jul 1, 1989Paper

T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer

Head & Neck
C H SnydermanJ T Johnson

Abstract

Fresh suspensions of tumor-infiltrating lymphocytes (TIL) from 16 patients with squamous cell carcinoma of the head and neck (SCCHN) were examined for T-cell markers including CD4 (helper-inducer), CD8 (cytotoxic-suppressor), natural killer (NK) cell, and activation surface markers using monoclonal antibodies and two-color flow cytometry. Two of 8 (25%) patients with a CD4/CD8 ratio of less than 1 developed cervical lymph node metastases; none had extracapsular spread. Six of 8 (75%) patients with a CD4/CD8 ratio of greater than 1 developed cervical metastases; 5 of 6 (83%) exhibited extracapsular spread. An increased CD4/CD8 ratio was attributable to a decrease in CD8+ cells. A CD4/CD8 ratio of greater than 1 may be a useful prognostic indicator of the development of cervical metastases.

References

Nov 15, 1979·International Journal of Cancer. Journal International Du Cancer·B M Vose, M Moore
Jan 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Von RoennD P Braun
Sep 1, 1986·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·G T WolfK D McClatchey
Jun 15, 1986·International Journal of Cancer. Journal International Du Cancer·T L WhitesideV von Fliedner
Aug 1, 1985·Archives of Otolaryngology·J T JohnsonP B Thearle
Jul 1, 1984·American Journal of Clinical Pathology·J T ThornthwaiteD A Vazquez
Oct 12, 1984·Journal of Immunological Methods·J K NicholsonJ S McDougal

❮ Previous
Next ❯

Citations

Oct 1, 1995·Cancer Immunology, Immunotherapy : CII·J HaldM H Claesson
Nov 8, 2011·Cancer Immunology, Immunotherapy : CII·Neil L BerinsteinJohn W Hadden
Mar 24, 2005·Cancer Metastasis Reviews·Theresa L Whiteside
Aug 1, 1998·Otolaryngologic Clinics of North America·L P Kowalski, J E Medina
Oct 26, 1999·Critical Reviews in Oncology/hematology·J D KerrebijnH A Drexhage
Feb 27, 2008·Cancer Biotherapy & Radiopharmaceuticals·David LooseChristophe Van de Wiele
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J Nemunaitis, J O'Brien
Oct 28, 2005·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·S GronauM Schmitt
Jul 8, 2010·International Journal of Oral and Maxillofacial Surgery·J J LeeJ H Jeng
Dec 21, 2011·The Laryngoscope·Clint T AllenRavindra Uppaluri
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D VitoloT L Whiteside
Mar 1, 1992·The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society·G J Gianoli, R H Miller
Nov 1, 1994·Acta Oto-laryngologica·F M GonzálezA Durántez
Mar 22, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Nancy P JuddRavindra Uppaluri
Jan 1, 1994·Aesthetic Plastic Surgery·C J van den Helder, J J Hage
Sep 4, 2003·Journal of Neuro-oncology·John S YuChristopher J Wheeler
Sep 1, 1994·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·C H SnydermanT L Whiteside
Mar 1, 1993·Current Problems in Surgery·J P ShahJ R Marti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.